Assessment pathways and value demonstration requirements for digital health technologies ​

• An eminent UK academic institution was in the process of developing policy recommendations regarding the optimal processes/evidence requirements for the commissioning of digital health technologies ​
• This required a detailed understanding of key examples/implications of assessment processes for digital health technologies across other global markets, and stakeholder perspectives on the optimal approach for implementing digital products/software services within routine clinical practice ​

​

‍

• Review of the assessment pathways and procurement processes for digital health technologies across key global markets ​
• Understand key decision makers in the commissioning of digital health technologies and how the process operates at national, regional and local levels ​
• Understand the evidence requirements considered for the adoption/funding of digital health technologies (and how this could adapt to support access to innovation)​

• A desk research programme was completed to review pathways/evidence requirements for the assessment of digital health technologies/services across key global markets (including products evaluated/reimbursed through these processes)​
• Primary research has completed with relevant national/regional/local level stakeholders to understand the practical operation of current pathways, implications for evidence requirements to support pricing, patient access and uptake for digital health technologies/services and predicted areas for future development ​

‍

• The client /services across priority markets, and recommegained a detailed understanding of the current/evolving landscape for the evaluation and funding of digital health technologiesnded areas for reform to support enhanced patient access/uptake ​
• This directly informed the development of policy recommendations for optimisation of existing processes/pathways for the assessment and funding of digital health technologies ​

‍